Suricog
- Company typePrivate
- Founded2013
- HeadquartersParis, France
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Suricog does
Suricog is a French private MedTech company founded in 2013 by physician-entrepreneur Marc Massonneau and headquartered in Paris, specializing in medical oculometry — the quantification of brain disorders through analysis of eye movements. The company's integrated solution pairs the EyeBrain NEO software, a Class I CE-marked medical device under MDR, with the Weetsy wearable eye-tracking glasses that capture eye position at 300Hz. The platform records and analyzes oculomotor responses to visual stimuli and supports clinical assessment across 12+ pathologies including ADHD, Alzheimer's, Parkinson's, Multiple Sclerosis, Autism, Dyslexia, and Schizophrenia. Suricog acquired the E(ye)BRAIN software platform from a €10 million research program in 2016 to complete its medical portfolio.
Suricog sells primarily through a direct, enterprise sales motion targeting French University Hospitals (CHUs), where it claims over 50% installed penetration, alongside orthoptic, neurology, mental health, ophthalmology, and pediatric practices. Revenue streams comprise one-time hardware sales (Weetsy), one-time software licensing for the EyeBrain NEO platform (installed and configured by Suricog), and ancillary professional services including training, customization, and scientific collaboration. Marketing leverages French and European medical congresses (AFO, AREPO, EFO, SDO), peer-reviewed scientific publications, and a healthcare-professional-gated website with contact-based quoting.
The company has expanded its clinical validation partnerships to over 50-100 clinical teams globally and received the 2024 Marcel Dassault Innovation Prize for Mental Illness for a school-based Neurodevelopmental Disorders early-detection project. Ownership remains concentrated with the founder; disclosed external funding is modest (~$108K from WILCO in 2014 and earlier AGORANOV support), and the company lists no patents despite its interdisciplinary positioning at the intersection of optoelectronics, neuroscience, and algorithms.
Suricog firmographics
Firmographics- Name
- Suricog
- Legal name
- SURICOG
- Website
- https://suricog.fr
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Suricog industry classification
Industry- Product category
- Medical Oculometry Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Visual Field & Functional Vision Testing (Perimetry, ERG/VEP, Contrast Sensitivity) (HLAHAJAC)
- akta.pro secondary industries
- Pediatric Ophthalmology & Orthoptics Devices (Amblyopia Therapy, Strabismus Measurement & Treatment) (HLAHAJAM), Neuro-Ophthalmology (HLAKAKAH), Vision Therapy & Orthoptics (HLAKAKAM)
Keywords
Where Suricog is headquartered
LocationHeadquarters
- HQ city
- Paris
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
Suricog business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Others
Revenue model
- Eye Tracking Hardware Sales: Sale of Weetsy eye-tracking hardware devices available in two sizes for different patient morphologies. One-time hardware purchase with associated accessories.
- EyeBrain NEO Software: Class I medical device software for oculomotor assessment. Sold as part of integrated solution with hardware. Device installation and configuration performed by SURICOG.
- Professional Services and Training: Complete range of services including device usage guidance, customization, practice assistance, and training. Scientific unit dedicated to collaborative research projects. Webinars and seminars available.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
Suricog product offering
Product offeringCore offering
Suricog develops and sells an integrated medical oculometry solution combining proprietary eye-tracking hardware (Weetsy glasses, 300Hz) with Class I CE-marked medical device software (EyeBrain NEO) that records and analyzes eye movements in response to visual stimuli for the objective diagnosis and monitoring of neurological and psychiatric disorders across 12+ pathologies including Alzheimer's, Parkinson's, ADHD, autism, schizophrenia, and multiple sclerosis.
Product overview
Suricog offers a complete medical oculometry solution comprising two main integrated products: EyeBrain NEO software (a Class I medical device) and Weetsy eye tracker hardware (glasses form factor). EyeBrain NEO provides the diagnostic interface for characterising oculomotor dysfunctions, while Weetsy serves as the acquisition hardware capturing eye movements at 300Hz. The software platform enables patient database management, automated test execution, and report generation. Additional services include training, customization support, and dedicated scientific research collaboration. The company also acquired the original E(ye)BRAIN software platform in 2016, which continues to be part of the product portfolio.
Differentiator
Problem solved
Functional benefit
Brands
- EyeBrain NEO: Medical device software (Class I) designed to help practitioners characterize oculomotor dysfunctions by recording and analyzing eye movements in response to visual stimuli.
- Weetsy
- E(ye)BRAIN
Products and services
- EyeBrain NEO Class I CE-marked medical device software that presents visual paradigms on screen while recording and analyzing patient ocular responses to characterize oculomotor dysfunctions; produces automated analysis and detailed shareable measurement reports for healthcare practitioners.
- Weetsy Wearable eye-tracking glasses with 300Hz acquisition frequency and high-resolution cameras, available in two sizes (small and large) for adults and children and compatible with prescription glasses; captures eye position every 3.3 milliseconds and can also acquire pupil diameter information.
- EyeBrain Software (E(ye)BRAIN platform) Proprietary software platform enabling patient file management, test selection and execution, automated analysis of results, and generation of customizable complete reports for oculomotor and neuro-visual assessment.
- Professional Services and Training
Quantifiable outcome
- Spatial accuracy of approximately 0.5 degrees for healthy subjects
- +3 more outcomes
Companies that use Suricog
Customer profileNamed customers3 records
Segments7 records
Ideal customer profiles2 records
Suricog technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Suricog partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Clinical Teams WorldwidecorePartnerships with over 50 clinical teams around the world (English site) or 100+ teams (French site) for clinical validation and research collaboration. These partnerships have generated scientific publications supporting the diagnostic utility of the technology across multiple pathologies.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
Suricog competitors and assessment
Company assessmentDirect peers
- Oculogica: Oculogica uses eye-tracking to detect concussions and other neurological conditions, with FDA-cleared products like the EyeBOX. It is a direct competitor in medical eye-tracking diagnostics, particularly in the brain-disorder quantification space that Suricog also addresses with its EyeBrain NEO platform.
- RightEye: RightEye is a US-based clinical eye-tracking platform that uses oculomotor and vision metrics to assess brain health, concussion, and reading disorders. It is a direct competitor to Suricog in the medical oculometry niche, targeting similar healthcare professionals (optometrists, neurologists) with an integrated hardware-plus-software solution for neurological and developmental assessment.
- SyncThink: SyncThink develops eye-tracking-based assessment tools primarily for concussion and balance disorders, with FDA clearance and partnerships across US sports medicine and neurology. It directly competes with Suricog in clinical oculometry for neurological diagnosis, addressing overlapping use cases with similar technology underpinnings.
Broad incumbents
- Natus Medical: Natus Medical is a major neurological and neurodiagnostic device company offering a broad portfolio used in hospitals and clinics. While not focused on oculometry specifically, Natus serves the same neurology customer base that Suricog targets and could be an acquirer or competitor if it expands into eye-tracking-based diagnostics.
- Seeing Machines: Seeing Machines develops eye-tracking and driver-monitoring technology with expanding applications in healthcare and fatigue/attention assessment. As a broad incumbent with public listing and global reach, it is comparable in the broader eye-tracking-for-health space, though its primary market is automotive safety.
- Tobii: Tobii is the largest commercial eye-tracking technology company, with products spanning research, healthcare, and consumer applications including medical-grade and clinical offerings. As a broad incumbent, Tobii has the resources and global sales reach to encroach on Suricog's medical oculometry niche if the market expands.
Emerging players
- NeurOptics: NeurOptics specializes in pupillometry devices used in neurology and critical care for objective neurological assessment. While focused on pupil response rather than full oculomotor analysis, it serves overlapping clinical customers (neurologists, ICUs) and is comparable as a medical eye-tracking/diagnostic peer.
- CNS Vital Signs: CNS Vital Signs provides computerized neurocognitive assessment tools used by clinicians to evaluate brain function across multiple domains. It is comparable as a digital neurology diagnostics peer addressing overlapping clinical customers (neurologists, psychiatrists) seeking objective cognitive and neurological measurements, though it relies on computerized testing rather than eye-tracking.
- iMotions: iMotions provides a biosensor platform that integrates eye-tracking with other physiological measures for research and healthcare applications. It is comparable to Suricog as an enabler of oculomotor and cognitive research, though positioned more toward research labs than clinical diagnostics.
- SR Research (EyeLink): SR Research manufactures EyeLink, a high-end research-grade eye tracker widely used in cognitive neuroscience labs and clinical research worldwide. While primarily research-focused, EyeLink is commonly used in the same clinical studies and orthoptic research environments where Suricog operates, making it a partial-overlap emerging player in clinical-grade oculometry.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Suricog social profiles
Digital presenceSuricog compliance and trust
Trust signalCompliance1 record
Suricog financial estimates
Financial estimateRevenue estimate
Valuation estimate
Suricog leadership team
Management profileNumber of profiles
Profiles6 records
Suricog funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Suricog M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Suricog
What does Suricog do?
Suricog develops and sells an integrated medical oculometry solution combining proprietary eye-tracking hardware (Weetsy glasses, 300Hz) with Class I CE-marked medical device software (EyeBrain NEO) that records and analyzes eye movements in response to visual stimuli for the objective diagnosis and monitoring of neurological and psychiatric disorders across 12+ pathologies including Alzheimer's, Parkinson's, ADHD, autism, schizophrenia, and multiple sclerosis.
Is Suricog a public or private company?
Suricog is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Suricog founded?
Suricog was founded in 2013. It employs 11 to 50 people.
Where is Suricog based?
Suricog is headquartered in Paris, France, in the Europe region.
How does Suricog make money?
Three revenue lines are on record. Eye Tracking Hardware Sales are the primary driver. The others are eyeBrain NEO Software and professional Services and Training.
Who are Suricog's main competitors?
Direct peers on record are Oculogica, RightEye and SyncThink. Broad incumbents are Natus Medical, Seeing Machines and Tobii. Emerging players are NeurOptics, CNS Vital Signs, iMotions and SR Research (EyeLink).
Does Suricog have an API?
No public API is recorded for Suricog.
What industry is Suricog in?
Suricog's product category is Medical Oculometry Devices. Its primary akta.pro industry code is HLAHAJAC, Visual Field & Functional Vision Testing (Perimetry, ERG/VEP, Contrast Sensitivity), with a secondary code of HLAHAJAM, Pediatric Ophthalmology & Orthoptics Devices (Amblyopia Therapy, Strabismus Measurement & Treatment). Its NAICS code is 334510 and its SIC code is 3841.